Uganda & United States — Food and Drug Administration

Uganda: Uganda>>> has reported confirmed Ebola cases linked to the outbreak in the Democratic Republic of the Congo>>>, leading to border closures and heightened surveillance efforts, while also expressing concern over the Uganda — Bundibugyo virus being named after one of its districts.

United States — Food and Drug Administration: The United States — Food and Drug Administration has approved Inmazeb, a combination of antibodies, to treat Zaire Ebolavirus infection, which Regeneron Pharmaceuticals has donated for potential use in the current outbreak.

Uganda: Country of a co-author, reflecting international collaboration.

United States — Food and Drug Administration: The FDA is the central regulator whose clearance process is criticized for not requiring outcome testing. The study could lead to policy changes affecting its approval pathways.

Uganda: Uganda has reported Ebola cases linked to the DRC outbreak, contributing to regional spread.

United States — Food and Drug Administration: The FDA granted EUA for OraSure's test, facilitating rapid deployment during a public health emergency.

Uganda: Uganda is cited as a model for local pharmaceutical production to encourage Nigerian pharmacists.

United States — Food and Drug Administration: NAFDAC is the regulatory agency that ACPN is called to collaborate with in fighting fake drugs.

Uganda: Uganda is also affected by the Ebola outbreak, and the CDC's response is critical. The new director's leadership may enhance international cooperation.

United States — Food and Drug Administration: The FDA is mentioned as another agency with a leadership vacancy, but it is not directly involved in this event.